Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study (Q46630310)
Jump to navigation
Jump to search
scientific article published in August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study |
scientific article published in August 2005 |
Statements
1 reference
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study (English)
1 reference
Russell J Schilder
1 reference
Michael W Sill
1 reference
Xiaowei Chen
1 reference
Kathleen M Darcy
1 reference
Steven L Decesare
1 reference
George Lewandowski
1 reference
Roger B Lee
1 reference
Cletus A Arciero
1 reference
Hong Wu
1 reference
Andrew K Godwin
1 reference
1 August 2005
1 reference
1 reference
11
1 reference
5539-5548
1 reference
15
1 reference
Identifiers
1 reference
1 reference